- Recommendation ID
- What is the effectiveness of statins and/or other LDL-cholesterol-lowering treatment in people with type 1 diabetes?
- Any explanatory notes
- People with type 1 diabetes have increased CVD risk derived from age, sex, glycaemia, blood pressure, renal function and lipid levels as identified in epidemiological studies. Long-term glycaemic control is associated with better outcomes but no trial has investigated the efficacy of statin therapy or other LDL-cholesterol-lowering therapies exclusively in people with type 1 diabetes.
Source guidance details
- Comes from guidance
- Cardiovascular disease: risk assessment and reduction, including lipid modification
- Date issued
- July 2014
|Is this a recommendation for the use of a technology only in the context of research?||No|
|Is it a recommendation that suggests collection of data or the establishment of a register?||No|